Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
| Distributed by / for | Preferred Pharmaceuticals, Inc |
| NDC | 68788-0048-03 |
| Full product label | Losartan Potassium Tab. USP 50mg, a) 30 count bottle (NDC 68788-0048-03) and b) 90 count bottle (NDC 68788-0048-09), Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA, Mfg: Torrent Pharma Inc., Basking Ridge, NJ |
| Recalling firm | Preferred Pharmaceuticals, Inc |
| Distribution | CA, GA, IN. No DOD/VA accounts. No foreign accounts. |
| Recall initiated | 2019-04-30 |
| Report date | 2019-05-22 |
| Recall completed | 2023-04-03 |
| Recall number | D-1281-2019 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Anaheim CA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗